The Africa Clinical Research Network (ACRN) has started its first clinical trial using Oracle's cloud-based safety and analytics solutions to study pre-eclampsia in African women. The PROTECT-Africa trial, running in Zimbabwe, Rwanda, and Tanzania, aims to validate biomarkers that predict severe pregnancy complications, recruiting over 1,100 participants. This initiative addresses the low representation of Africa in global clinical trials and seeks to build a sustainable research ecosystem across 14 African countries. By leveraging Oracle's technology, ACRN aims to enhance trial efficiency, patient safety, and accelerate access to relevant medical innovations for African populations.
A Nikkei study reveals that five major U.S. tech companies hold $1.65 trillion in hidden debt, far exceeding their reported liabilities. This debt has grown eightfold in four years, driven by heavy investments in artificial intelligence. Meta and Ora...
Oracle is repositioning itself as a major provider of large-scale AI infrastructure, embedding its data centers within competitors like Amazon and Google. Despite a recent credit rating downgrade to BBB- due to heavy AI infrastructure investments imp...
Oracle Corporation is under pressure due to its heavy investment in AI infrastructure tied to OpenAI, which is now trailing competitor Anthropic in AI model leadership and IPO progress. These investments have strained Oracle's free cash flow and incr...
Oracle remains a key player in AI with strong cloud growth and a 34% increase in earnings per share. However, the company's share price has fallen 43% due to elevated capital expenditures and declining free cash flow. Oracle's dividend payments have ...
